Amphioctopus neglectus (Family: Octopodidae) is recognised as culinary delicacy in many cultures and a common sea food item on the Mediterranean and Asian coasts. Bioassay-directed fractionation of ethyl acetate/methanol extract of A. neglectus ensued in the characterisation of four previously undescribed macrocyclic lactones (1-4). These compounds exhibited potential radical-scavenging capacities (IC 50 0.95-1.73 mM) along with anti-hypertensive activities (IC 50 1.12-2.34 mM) against angiotensin converting enzyme (ACE). The optimum binding affinity of compound 2 (−9.84 kcal mol −1 ) bearing furo [1, 4, 8] trioxacyclohexadecine-12,19-dione moiety with ACE, along with its permissible hydrophobic-hydrophilic balance, manifested towards its greater anti-hypertensive activity compared to other analogues. The compound 2, with lesser values of the inhibitory constant (K i = 1.0 mM) towards ACE, was found to bind more effectively to the enzyme in a non-competitive manner, and could describe the greater inhibitory ramifications than those displayed by other compounds (K i > 1.1 mM). The ex-vivo studies revealed that compound 2 imparted protective effects against angiotensin-II induced cardiac hypertrophy at 25 μg mL −1 on H9C2 cell lines, wherein about 34 percent decrease in cell area with increase in viability could be attributed to anti-hypertrophic effects of the compound administrated. These results confirmed that the protective effect of the isolated macrocyclic lactones is mediated by enhancement of anti-oxidant defense systems, which subsequently attenuates the hypertensive related disorders.
Introduction
The marine cephalopods belonging to family Octopodidae are gaining commercial significance due to their high nutritive values and various pharmacological potentials [1] . The marine octopuses (Family: Octopodidae) are ubiquitous throughout the oceans, and have been recognised as high-value health food for human consumption [2] . Globally octopus landing and consumption have increased 6.7 percent in 2016 compared with 2014. The increase was registered in major suppliers (Morocco, Mauritania and Mexico), and Japan experienced a significant increase in imports of octopus [2] . Among various cephalopods, Amphioctopus neglectus (neglected ocellate octopus, Family: Octopodidae) is widely distributed in marine waters, and has been considered as culinary delicacy at various parts of world. Previous reports of literature recognised the anti-oxidant and anti-hypertensive activities of crude extract [3, 4] and bioactive compounds from the edible tissues of the genus [5] . The octopus as a food is a remedy to fight diseases, such as atherosclerosis, cardiac arrhythmia, eczema, macular degeneration, rickets etc., and is a source of taurine that helps reducing cholesterol from blood vessels thereby preventing formation of blood clots in body [6] . Angiotensin-I-converting enzyme (ACE-I) in the rennin angiotensin aldosterone system (RAAS) displayed an important part in the modulation of blood pressure and cardiovascular function, as it converts the inactive decapeptide angiotensin-I (Ag-I) into the potent vasoconstricting octapeptide angiotensin-II (Ag-II), which potentially narrows the opening of a blood vessel lumen and increases vascular resistance. Additionally, Ag-II plays a pivotal role in the release of aldosterone, from the adrenal cortex and subsequently leads to hypertension. ACE is a multifunctional enzyme that also catalyses the degradation of bradykinin, a vasoactive nonapeptide helpful in arteriolar dilation and increased capillary permeability in the kallikrein-kinin system [7] . Hypertension is a metabolic disorder that is implicated by a consistent increase in blood pressure, and has been considered as the critical threat for cardiovascular disease (CVD) all through the world. Previous report of literature demonstrated that there had been nearly 1 billion ailing individuals with CVD at the end of https://doi.org/10.1016/j.biopha.2018.11.0342000, and was anticipated to reach more than 1.5 billion during 2025 [8] . The presence of excess reactive oxygen species in biological systems was found to assume an essential part in the homeostasis of vascular wall through disruptions in the biochemical pathway of RAAS, and subsequently contribute towards the pathophysiology of hypertension [9] . Thus, an increased presence of anti-oxidants was recognised to be beneficial to combat hypertension and other related ailments [10] . Inhibition of ACE-I has been thought to be a restorative approach in the treatment of hypertension [7, [11] [12] [13] . Currently, synthetic anti-hypertensive medications are extensively used in clinical treatment of hypertension, and prolonged intakes of these synthetic analogues were reported to exhibit adverse effects [14] . Therefore, the search for food-based anti-hypertensive inhibitors are of immense appeal and functional food products could likely perform the necessity. Marine-based functional food is attaining immense consideration in nutraceutical industries due to their protective function against various chronic diseases and availability [15, 16] .
The oxygenated macrocyclic lactones or ethers were found to be 10-membered cyclic systems enclosing ester or ether functionalities, and were recognised as important sources of nutraceuticals or medicines with multiple bio-potentials [17] . These marine macrocyclic lactones were previously reported from invertebrates [18] , sponges [19] and algae [20] . The bioactive reaction centers of commonly utilised antioxidant agent, α-tocopherol and anti-hypertensive agent captopril were found to possess heterocyclic functionalities. However, the structureactivity analyses of captopril revealed that its lesser lipophilic value (manifested as logarithm of octanol-water partition coefficient, log P ow ) (log P ow 0.24) than ideal (2-5) might result in poor bioavailability [21] . Likewise, the greater lipophilic (log P ow 9.9) and steric factors of α-tocopherol might diminish its bioavailability [22] . Therefore, search for oxygenated macrocyclic ring framework as the basic anti-hypertensive center with higher polarisability and optimum lipophilicity (log P ow 2-5) descriptors could be vital for greater bioactivity. Molluscs have been extensively consumed as the culinary delicacies, and were reported to possess bioactive metabolites categorised under various classes of chemistries [23, 24] , such as macrocyclic ethers, oxygenated heterocyclics, polysaccharides, macrocyclic lactones etc., with promising pharmacological functions [16, 25] .
As a continuing program to investigate bioactive oxygenated macrocyclic lactone analogues from the economically important seafood species, ethyl acetate-methanol (EA-MeOH) extract of A. neglectus was partitioned by sequential chromatographic fractionation. In view of this, we have described the isolation and identification of four macrocyclic lactone derivatives for the first time. These were characterised using Fourier transform infrared (FTIR), nuclear magnetic resonance (NMR), and mass spectroscopic analyses. The macrocyclic lactone analogues identified in the present study were assessed for anti-oxidant activities by selective radical scavenging assessments, whereas their inhibitory properties against ACE enzyme, which is a component of renin-angiotensin framework to develop the pathophysiology of hypertension, determined their anti-hypertensive potentials. Structurebioactivity interrelationships of macrocyclic lactones were examined by different physico-chemical characteristics and modes of inhibition against hypertensive enzymes by kinetic analyses and molecular docking simulation studies. Ameliorating potentials of these compounds against hypertrophy prompted by Ag-II in H9C2 cells and their sequel on oxidant-induced stress were also determined.
Materials and methods

Samples and preparation of solvent extracts
The specimens of A. neglectus (5 kg) were collected afresh from the landing centre of Arabian-Sea located at Lat 8°48′ N, Long 78°9′ E; Lat 9°14′ N, Long 79°14′E, through the Southwestern coast of the Indian subcontinent. The species was cleaned to remove debris and other dirt remains. The ink-gland was carefully separated, and the edible part homogenated. The ground samples were lyophilised by using a freezedrier (Labogene Scanvac Cool Safe, Denmark) yielding the freeze-dried powder (1500 g, yield 30%). The lyophilised powder was extracted in EA-MeOH (1:1, v/v, 1000 ml × 3) by way of sonication (8 h) under an inert atmosphere. The organic fraction was filtered by anhydrous sodium sulfate (Na 2 SO 4 ) taken after by vacuum evaporation on a rotavapour (50°C; Heidolf, Germany) to afford the crude extract of A. neglectus (68 g, yield 4.5% on dry weight basis).
Chromatographic partitioning and spectroscopic identification
The crude EA-MeOH extract of A. neglectus (68 g) was sequentially partitioned by column chromatographic fractionation. The crude was homogenated with coarse silica (60-120 mesh, 5 g) and packed into the open glass column (100 cm × 4 cm) charged with silica gel (60-120 mesh, 85 g). The column was primarily eluted with n-hexane followed by EA and MeOH, to acquire a total of 5 column fractions (AM 1 through AM 5 ). The bioactive properties of AM [1] [2] [3] [4] [5] were examined, and two of them (AM 3 and AM 4 ) were chosen for additional fractionations owing to their higher anti-hypertensive and anti-oxidant properties against ACE-I (IC 50 < 1 mg mL −1 ) contrasted to others (IC 50 > 1.25 mg mL −1 )
( (Fig. S33 ). [1, 15] (Fig. S44 ).
(Z)-12-Hydroxy-14-methyl-4-(pentan-19-yl)-octahydro-benzo
Anti-oxidant, anti-hypertensive assays and structure-bioactivity interrelationship analysis
Anti-oxidant assays
The anti-oxidant properties of the studied macrocyclic lactones (1-4) isolated from A. neglectus were resolved by in vitro DPPH and ABTS + (2, 2′-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) radicalscavenging analyses [26] . The percentage inhibition (%) was calculated as follows: [(A CL -A SL )/A CL ) * 100], where A CL and A SL represented the absorbance of control and sample, respectively. Median inhibitory concentration of the compounds were calculated [27] , and the results were showed as IC 50 (mM), the concentration at that they inhibit the free-radical activities to their half.
Anti-hypertensive assay
The studied compounds, 1-4 were assayed for their potential to inhibit the ACE-I activity. ACE inhibition activity was manifested as reaction rate (δA min The concentration of compounds that blocked ACE activity to its half of the original activity (IC 50 ) was calculated [13] .
Structure-bioactivity interrelationship analysis
The molecular physico-chemical characteristics, such as hydrophobic (logarithmic value of octanol/water partition coefficient, log P ow ), polar (polarisability Pl and topological polar surface area tPSA), and bulk (Pr parachor, MR molar refractivity, and MV molar volume) parameters were used to study the structure-bioactivity interrelationship analysis of the of the macrocyclic lactones [28] . These parameters were deduced by ACD ChemSketch (version 12; ACD Inc., Canada) and ChemDraw Ultra (version 12.0; Cambridge Soft Corporation, MA, USA) programs.
Kinetics of ACE inhibition
Kinetic analyses by Dixon and Lineweaver-Burk plots were used to assess mechanism to inhibit ACE by the macrocyclic lactone analogues (1-4). The ACE-I inhibition was surveiled at different concentrations (0.0625, 0.125, 0.25 and 0.5 mM) of substrate N- [3-(2- 
, in presence and absence of the compounds, in Lineweaver-Burk double-reciprocal plots. The compounds were used in different concentrations, and the inhibitory activities were expressed in mM. The kinetic parameters, such as maximum rate of ACE-catalysed reaction (V max ) and Michaelis constant of ACE (K m ) were determined as intercepts in Y and X-axis of LineweaverBurk double-reciprocal plot [29] . The inhibition constant (K i ) was calculated by elucidation of Dixon plots (single reciprocal plot), which DEPT NMR spectrum. The assignments were made with the aid of the COSY, HSQC, HMBC and NOESY experiments. The stereo-chemical orientations in the structures were represented by wedge-faced and dash-faced bonds based on NOESY spectra.
were set up by representing 1/V against substrate (inhibitor) concentrations.
In silico molecular docking analysis
Molecular docking analyses of the studied macrocyclic lactones were accomplished by using the docking software (Autodock 4, version 1.5.6), to evaluate the conformation of ligand-protein framework. The titled compounds were built with Chemsketch software (version 3.5) before being saved as MDL-molfiles, which were transformed to PDB format with Open Babel GUI (version 2.4.1). The crystal structure of ACE-I (PDB: 1UZE; resolution 2.0 Å) [30] was recovered from protein databank (dedicated website, www.pdb.org), wherein the water molecules were eliminated from target enzymes, and the structure of protein was energetically diminished (Swiss-PdbViewer SPDBV v4.1.0). The diminished protein was accounted for molecular docking analysis to assess their feasible binding manner between the ACE-I active sites, calculate the energy of complex and binding affinity. The cofactors, ligands, and protein-bound water were removed while carrying out the docking analysis. The target enzyme was examined for partial atoms and polar hydrogens, where Kollman charges were designated. Torsion bonds of the studied macrocyclic lactones were chosen and defined, wherein the 3D-grid box was generated by Auto-Grid calculation to assess the coupling energies on the ACE-coordinates. Grid map set values for docking of ACE-I were selected as x = 39.979, y = 37.622, z = 50.808 (56 Å × 58 Å × 58 Å) points. The running of the docking calculation was utilised using Cygwin-1/Cygwin-2, and root-meansquare deviation was studied for assessing lowest energy of binding. A chimer programming (University of California, San Francisco-UCSF) was utilized for representation and investigation of results to perceive H-bonding connections between designated macrocyclic lactones and target ACE-I.
Ex-vivo study to inhibit angiotensin-II (Ag-II) induced cardiac hypertrophy on H9C2 cells
Ex-vivo studies were performed to demonstrate the inhibition of angiotensin-II (Ag-II) induced cardiac hypertrophy on H9C2 cells. Cardiomyoblast (H9C2) cell line was obtained from the NCCS (National Centre for Cell Sciences) of Pune, India, and was preserved in Dulbecco's Modified Eagles' Medium (DMEM) (Sigma Aldrich, USA). The H9C2 cell lines cultured with DMEM, were added with fetal bovine serum (10% FBS), amino acid L-glutamine, sodium hydrogen carbonate along with a solution containing the antibiotics streptomycin (100 μg mL −1 ), penicillin (100 U mL −1 ), and amphoteracin-B (2.5 μg mL −1 )
before being maintained in a CO 2 incubator (NBS Eppendorf, Germany) retained at a temperature of 37°C and 5% relative humidity. The growth of cells was assessed by directly examining the cells with an inverted phase-contrast microscope (20 × magnification) before being analysed by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay. The inhibitory potential of the compound attenuating cardiac hypertrophy on H9C2 cell lines by Ag-II was analysed by morphological changes using inverted phase contrast tissue culture microscope (20 × magnification) by crystal violet staining method followed by image analysis using Image J analysis software.
Cell seeding in 96-well plate and preparation of compound stock
Two-day old coalescent cell-monolayer was trypsinised before being dispersed in the cell growth medium (10%). The suspension of cells (100 μL, 5 × 10 4 cells well −1 ) was implanted in 96-well plate and maintained in a CO 2 incubator (NBS Eppendorf, Germany) retained at a temperature of 37°C and 5% relative humidity. The selected compound (1 mg) was dissolved in DMEM (1 mL) with a cyclo-mixer before being clarified with a syringe filter (Millipore, USA, 0.22 μ) to ensure the sterility.
Cytotoxicity evaluation by direct microscopic observation
After acquiring adequate growth of the H9C2 cell lines, angiotensin (100 μM) was added to induce toxicity and the mixture was incubated for 1 h. The studied compound (in DMEM, 5%) were serially diluted (5×) by two-times dilution (100 μg, 50 μg, 25 μg, 12.5 μg and 6.25 μg in 500 μl of DMEM). Each concentration (100 μL) was added to the wells before being incubated (37°C, 5% RH) for 24 h. Entire plate was observed after the incubation period with a phase-contrast (inverted) microscope at 20× magnification (CKX-41, Olympus, USA), wherein any perceivable alteration in the cellular morphology, for example, shrinking or rounding, vacuolisation and granulation of cell cytoplasm were contemplated as markers of cytotoxicity. The surface area of cells from each group (40 to 50 cells group −1 ) was determined and compared with the control group (untreated H9C2 cell lines) using Image J analysis software.
MTT-based cytotoxicity appraisal
MTT (15 mg, Sigma, M-5655) was added with the phosphate buffer saline (PBS, 3 mL) till thoroughly dissolved before being filter-sterilised and incubated for 24 h. The samples in wells were separated, MTT solution (30 μL) was added to the plate wells, and the contents were incubated (37°C, 5% RH) for 4 h. Following the incubation, the clear upper layer was removed, and dimethyl sulfoxide (100 μL) was added in the wells with gentle mixing in order to dissolve the crystals of N'-amino-N-iminomethanimidamide (formazan). The absorbance values were analysed (at 540 nm), and the growth inhibition (as percent) was calculated as [OD samples ×100)/OD control ].
Statistical analysis
The statistical software SPSS (Statistical Program for Social Sciences, version 13.0; USA) was utilised to ascertain the significant difference by using ANOVA (one way analysis of variance) between means. The results were presented as the mean of replicate experiments with a 5% level of significance (p < 0.05).
Results and discussion
General
The marine cephalopods belonging to family Octopodidae represent a considerable share in the fishery sector, and were described to hold structurally different bioactive metabolites with respect to various pharmacological activities [4] . The present study deals with isolation of bioactive oxygenated macrocyclic lactone metabolites from EA-MeOH extract of A. neglectus using extensive spectroscopic techniques. The bioactive properties of isolated macrocyclic lactone analogues with respect to their anti-oxidant and anti-hypertensive activities using in vitro and ex vivo pharmacological models were assessed.
Chromatographic fractionation and structural characterisation of macrocyclic lactones from A. neglectus
The EA-MeOH extract of A. neglectus was firstly fractionated to five key sub-fractions (AM 1 -AM 5 ), and among which AM 3 and AM 4 displayed significantly greater recovery (24-26 %) than AM 1 , AM 2 and AM 5 (< 20%). The sub-fractions, AM 3 (Table S1 ). Therefore, AM 3 and AM 4 were selected for downstream chromatographic purification to obtain four macrocyclic lactone derivatives (1) (2) (3) (4) . The structures of the studied compounds were elucidated by inclusive spectroscopic techniques (Fig. 1) . The 10-membered cyclic lactone derivative, 5-((Z)-hex-12-enyloxy)- with diesters and triesters along with 14-membered diesters were previously reported from marine organisms [32, 33] . The basic skeleton of bislactone ring fused to tetrahydro furan exhibiting four spin systems was proposed on the basis of COSY correlations, which were found to be was isolated from crude EA-MeOH extract of A. neglectus by chromatographic separation. Six hydrogen bond deficiencies equivalent to two ring systems and four double bonds of 3 were attributed by detailed spectroscopy. The compound 3 was enclosed a 10-membered cyclic lactone ring fused to ethyl cyclohexene ring at C-11 and C-6. Ethyl cyclohexene ring was bonded to methoxyethyl butyl acetate side chain at C-10 that was attributed by detailed 1 Notably, the previously reported rearranged 13-membered macrolides was found to be a benzoate-fused macrocyclic ring [35] . Herein, the titled compound enclosed 13-membered lactone fused to the cyclohexenyl ring, which was proposed by the combination of HMBC/ 1 H-1 H COSY correlations. The compound enclosed four spin systems in which three belonged to pentanyl marolactone ring and one to the cyclohexenyl ring. The COSYs, such as δ 2. The lesser coupling constants of 2.9 and 3.8 Hz {eCH(6)]CH(7)e} suggested the cis-orientation of alkenic groups in the macrocyclic ring system. NOE couplings between the protons at δ 2.11 (H-4)/4.05 (Hβ-17) recognised their closer spatial alignments, and therefore, arbitrarily designated as β-disposed. Thus, the pentanyl chain at C-4 was trans oriented being opposite to β-disposed proton at δ 2.11. Also, NOEs were recorded between δ 3.33 (H-12)/4.34 (Hα-17), which indicated their equal molecular plane of symmetry, and thus, assigned as α-disposed. The hydroxyl at C-12 was β-disposed being opposite to the proton at δ 3.33. The IR spectrum of 4 registered stretching absorptions at 3439, 2925-2855, 1624, and 1736 cm −1 corresponding to the hydroxyl, alkanes, alkenes and carbonyl groups, respectively. The molecular ion at m/z 350 yielded m/z 316 through the elimination of methyl and hydroxyl radicals. The fragment at m/z 267 underwent hydroxyl and repeated ethyl radical eliminations to form m/z 130 corresponding to C 7 H 14 O 2 fragment, as the base peak.
Bioactive properties of macrocyclic lactone derivatives from A. neglectus
The studied macrocyclic lactones manifested prospective bioactive properties against various oxidative agents (ABTS + /DPPH % ) and ACE-I that transform Ag-I to Ag-II, an active vasoconstrictor ( Table 2 ). The macrocyclic derivatives bearing furo [1, 4, 8] trioxacyclohexadecine-12,19-dione moiety (2) and substituted 2-oxobenzo [1, 12] dioxecin-10-yl) acetate (3) showed significantly higher (p < 0.05) anti-oxidant potential against DPPH % (IC 50 0.95 and 0.98 mM, respectively) than those reported by 1 and 4 (IC 50 1.34 and 1.73 mM respectively), and α-tocopherol (IC 50 > 1.26 mM). The compound 2 displayed significantly higher ABTS + inhibitory activity (p < 0.05) than other compounds, notwithstanding that their bioactivities were significantly higher when corresponded to α-tocopherol (IC 50 1.75 mM; p < 0.05). The macrocyclic derivatives, 2 and 3 exhibited notably higher (p < 0.05) antihypertensive properties against ACE-I enzyme (IC 50 1.12 and 1.17 mM) proceeded by 1 (IC 50 2.43 mM) and 4 (IC 50 1.85 mM), in declining order.
The anti-oxidant potentials of a macrocyclic lactone metabolite were previously reported from the Babylonidae gastropod mollusc Babylonia spirata, and it was found that its molecular descriptors played significant roles to impart free radical scavenging potential in the biological system [28] . Additionally the anti-hypertensive bio-potentials of the metabolites were corroborated with their molecular descriptors wherein hydrophobicity and electronic variables played considerable roles towards their bioactivities [13] .
The macrocyclic lactone analogues showed hydrophobicity-lipophilicity equilibrium within the boundaries of optimum threshold (log P ow 2.0-3.5) ( Table 2) . Notably, the hydrophobicity of compounds 2 and 4 were similar, and within the acceptable thresholds (log P ow 3.2-3.3), although the lesser electronic properties of benzo [1, 15] interaction of latter at the enzyme active site leading to its greater ACE inhibitory activity. Notably, log P ow of a compound between 2-5 was contemplated to be optimum in enabling a steady hydrophobicity-lipophilicity interaction [36] . The macrocyclic lactone (2) was found to possess greater numbers of reaction centres, which were implicated by greater number of ester groups resulting in effective electron delocalisation to form keto-enol tautomers through resonance stabilisation. The latter appeared to assist in relocating the protons to neutralise the DPPH radical, and subsequently imparted anti-oxidant activity. However, other functionalities, such as unsaturations and ether moieties also possessed considerable roles towards increasing the total polar surface area and polarisability index, which appeared to increase its target bio-potentials [37] . Notably, the electronic properties of compounds 2 and 3 were greater (tPSA 71-91) as compared to those recorded with substituted 7-hydroxy-5-methyl-1, 4-dioxecan-10-one (1, tPSA 65) and octahydro-benzo [1, 15] dioxacyclotridecin-2-one (4, tPSA 56) analogues ( Table 2 ). The steric properties did not appear to contribute important part in bioactivities of the studied compounds. The higher molecular polarisability (which characterised the electronic systems) along with balanced hydrophobicity-hydrophilicity coefficient of compound 2 (log P ow 3.20) disclosed its greater bioactivities compared to other studied compounds [38] . It could be inferred that antioxidative potency of the macrocyclic lactone analogues might potentially inhibit the ACE-I enzyme, and subsequently retard the hypertension-related ailments [39] .
Kinetic properties of ACE-I inhibition
The means of inhibition and inhibition constants (K i ) of macrocyclic lactone derivatives (compounds 1-4) were determined by Dixon and Lineweaver-Burk plots. The isolated compounds were deduced to inhibit ACE-I in a non-competitive fashion as determined by the Lineweaver-Burk plot (Fig. S45-S48 ). This implied that the compounds were bound at an alternate site from that of the substrate, and thus goes about as ACE inhibitors by shaping enzyme-substrate-inhibitor or enzyme inhibitor edifices that would diminish effectiveness of enzyme catalysis. The mode of inhibition of ACE activity in the being of studied compounds was asserted by the decreased apparent V max and stable K m values, which were deduced from the Lineweaver-Burk plot. The inverse relation of V max with inhibitor (studied macrocyclic lactones, 1-4) concentrations appropriately recognised the typical character of noncompetitive inhibition [40] . Among the studied compounds, furo [1, 4, 8] trioxacyclohexadecine-12,19-dione derivative (2) exhibited lesser apparent V max (0.51-0.14 ΔA/min) than other macrocyclic lactones, which implied that it could efficiently bind with ACE-I to retard the velocity of the enzyme reaction (Table S2 ). The Dixon plots of ACE-I reaction in presence and without metabolites (1-4) at three different concentrations were displayed in Fig. 2 A-D. The K i values deduced from the Dixon plots were directly proportional to the ACE-I inhibition by isolated macrocyclic lactones. Notably, the compound 2, with lesser values of the inhibitory constant (K i = 1.0 mM) towards ACE-I, was found to bind more effectively to the enzyme in a non-competitive manner, and could describe the greater inhibitory ramificatons than those displayed by other compounds (K i > 1.1 mM).
In silico molecular docking analysis of the macrocyclic lactones
The in silico molecular docking analyses of the isolated macrocyclic lactones (1-4) were performed against ACE-I enzyme, and their RMSD results were studied (Fig. S49) . The hydrogen-bonded amino acyl residues and free energy between the macrocyclic lactones and ACE-I active sites were recorded (Table 3) . A grid box larger enough to cover the potential binding site of ACE-I was ascribed with the coordinates, x = 39.979, y = 37.622, z = 50.808 (56 Å × 58 Å × 58 Å) [41] . In silico molecular docking analyses of macrocyclic lactones with ACE-I disclosed that the docked ligands could conceivably bind with target, and displayed reduced binding energies (−8.03 to −9.84 kcal mol −1 ).
Particularly, furo [1, 4, 8] trioxacyclohexadecine-12,19-dione derivative (Fig. 3, Fig. S49 ). The macrocylcic lactone 4 displayed two hydrogen bonds with two His 353.A and Ser 335.A, whereas 1 exhibited one hydrogen bond with Gly 404.A (Table 3) . Additionally, the titled ligands (1-4) possessed specific interaction with the molecular receptor (ACE-I), and were found to be lesser than 3.5 Å, which subsequently implicated their effective binding property to form ligand-protein complex [42] . In the current study, the ligand (2) exhibited binding energy of −9.84 kcal mol −1 with ACE-I protein target that was found to be comparable with the standard anti-hypertensive agent captopril displaying a binding affinity of −9.66 kcal mol −1 [42] . The intermolecular energy were inferred to be lesser for macrocylic lactones, 2 and 3 (−10.95 and −10.84 kcal mol −1 , respectively) compared to those displayed by 4 (−9.25 kcal mol −1 ) and 1 (−8.93 kcal mol −1 ).
The least binding and intermolecular energies of compound 2, thus, inferred its more prominent ACE-I inhibition activity. . The compound 2 was found to regenerate the cardiomycetes. [1, 4, 8] trioxacyclohexadecine -12,19-dione (2) 
Ex-vivo study of macrocyclic lactone derivative bearing substituted furo
to inhibit angiotensin-II induced cardiac hypertrophy on H9C2 cell
Enzyme inhibition kinetic study and molecular docking simulations displayed that the macrocyclic lactone derivative bearing substituted furo [1, 4, 8] trioxacyclohexadecine-12,19-dione (2) possessed potent ACE-I inhibitory properties compared to other analogues. Hence, compound 2 was chosen for cytotoxicity studies, and to attenuate Ag-II prompted cardiac hypertrophy on H9C2 cell. Likewise, the compound 2 did not induce cytotoxicity on H9C2 cells, and at 25 μg mL −1 exhibited maximum viability (86%). The inhibitory potential of macrocyclic lactone derivative (2) to attenuate Ag-II prompted cardiac hypertrophy on H9C2 cell lines recognised that the cells appeared to undergo significant morphologic changes, when exposed to 100 mM of Ag-II for 24 h (Fig. 4) . Notably, angiotensin treatment increased the cell area to 6916.218 ± 584 μm 2 when compared to the untreated control samples (852.151 ± 79 μm 2 ) (Table S3 ). Enlargement and apoptotic loss of cardiomycytes were the key pathological changes in cardiac hypertrophy, resulting in tissue hypoxia and successive loss of cardiomyocytes resulting in heart failure [43] . In the present study, the enlarged and apoptic cells showed the cell regeneration after the treatment of macrocyclic lactone derivative (2) at different concentrations (6.25-50 μg mL −1 ). Image J analysis displayed that treatment with compound 2 exhibited a dose-dependent decrease in cell area suggesting anti-hypertrophic effects. The average cell area of hypertrophied H9C2 cell lines, upon the induction of the studied compound at 12.5 μg mL -1 was found to be 3695.594 ± 285 μm 2 , and 913.354 ± 84 μm 2 at 50 μg mL -1 test concentrations (Table S3 ). The ex-vivo studies revealed that compound 2 imparted protective effects against Ag-II induced cardiac hypertrophy at 25 μg mL −1 on H9C2 cell lines, wherein about 34 percent decrease in cell area with increase in viability could be attributed to anti-hypertrophic effects of the compound administrated. Therefore, the compound 2 was found to regenerate the cardiomycetes. A significant reduction of about 86.8% in cellular size of the hypertrophied H9C2 cell lines upon treatment of the macrocyclic lactone derivative bearing furo [1, 4, 8] trioxacyclohexadecine-12,19-dione moiety (2) appropriately recognized the potential of the studied compound to attenuate Ag-II induced cardiac hypertrophy. The decrease in the cellular size of the hypertrophied H9C2 cell lines, upon the induction of the protective agent, is the principal factor, which could be considered for the antihypertensive properties [44] . It is of note that elevated levels of reactive oxidative species appeared to impede cardiomyocyte functionality by impairing the ion channels that could damage the structural coherence of ion channels [45] . Since reactive oxidative species act as signaling molecules to develop cardiac hypertrophy, agents that occlude the generation of reactive oxidative species would have medicinal significance against cardiovascular ailments.
Conclusions
ACE, a multifunctional enzyme has been considered as an imperative constituent of renin-angiotensin framework to biosynthesise Ag-II, an active vasoconstrictor to induce hypertension and other related disorders. Inhibition of ACE is considered to be an important therapeutic approach in the treatment of hypertension. Marine-derived bioactive compounds are seeking immense attention in the treatment of Ag-II induced cardiac hypertrophy, and the current study reported four hitherto undescribed macrocyclic analogues from the organic extract of A. neglectus with inhibitory properties against ACE. Among the studied oxygenated macrocyclic lactones, the one bearing substituted furo [1, 4, 8] trioxacyclohexadecine-12,19-dione moiety (2) possessed potent ACE-inhibitory properties compared to other analogues. Therefore, it was chosen for cytotoxicity studies, and to attenuate Ag-II prompted cardiac hypertrophy on the H9C2 cell. The ex vivo studies also implicated that compound (2) significantly inhibited Ag-II induced cardiac hypertrophy on H9C2 cell, and therefore, could be utilised to develop potential pharmacophore lead against hypertension and related ailments. Owing to their potential bioactive properties, an approach to develop synthetic macrocyclic lactone leads for use against hypertensive-related disorders could be anticipated.
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